Shares of H. B. Fuller Company (NYSE:FUL – Get Free Report) have earned a consensus rating of “Moderate Buy” from the nine research firms that are presently covering the stock, Marketbeat reports. One analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation, three have given a buy recommendation and two have issued a strong buy recommendation on the company. The average 1 year target price among brokers that have issued a report on the stock in the last year is $66.20.
Several research firms have recently commented on FUL. UBS Group assumed coverage on H. B. Fuller in a report on Friday, November 21st. They issued a “neutral” rating and a $60.00 price target for the company. Seaport Res Ptn raised H. B. Fuller from a “hold” rating to a “strong-buy” rating in a report on Friday, September 26th. Citigroup upgraded shares of H. B. Fuller from a “neutral” rating to a “buy” rating and boosted their target price for the stock from $62.00 to $70.00 in a research report on Wednesday, October 22nd. Wall Street Zen downgraded shares of H. B. Fuller from a “buy” rating to a “hold” rating in a report on Monday, November 24th. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of H. B. Fuller in a research note on Monday, December 1st.
Get Our Latest Stock Analysis on H. B. Fuller
H. B. Fuller Stock Up 0.1%
H. B. Fuller (NYSE:FUL – Get Free Report) last announced its quarterly earnings data on Wednesday, April 13th. The specialty chemicals company reported $0.66 EPS for the quarter. H. B. Fuller had a net margin of 3.28% and a return on equity of 11.49%. The firm had revenue of $725.90 million during the quarter. H. B. Fuller has set its FY 2022 guidance at $4.100-$4.350 EPS. As a group, equities research analysts predict that H. B. Fuller will post 4.07 earnings per share for the current year.
H. B. Fuller Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Thursday, October 30th. Stockholders of record on Thursday, October 16th were paid a dividend of $0.235 per share. The ex-dividend date of this dividend was Thursday, October 16th. This represents a $0.94 annualized dividend and a dividend yield of 1.6%. H. B. Fuller’s payout ratio is 50.81%.
Insider Buying and Selling
In other H. B. Fuller news, VP Nathan D. Weaver sold 7,075 shares of the company’s stock in a transaction on Thursday, November 13th. The stock was sold at an average price of $58.38, for a total value of $413,038.50. Following the sale, the vice president owned 9,441 shares of the company’s stock, valued at approximately $551,165.58. This represents a 42.84% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO John J. Corkrean sold 14,222 shares of the firm’s stock in a transaction on Monday, October 27th. The shares were sold at an average price of $60.31, for a total value of $857,728.82. Following the completion of the transaction, the chief financial officer owned 54,646 shares of the company’s stock, valued at approximately $3,295,700.26. This represents a 20.65% decrease in their position. The SEC filing for this sale provides additional information. Corporate insiders own 1.99% of the company’s stock.
Institutional Trading of H. B. Fuller
Several large investors have recently modified their holdings of FUL. Partners Capital Investment Group LLP lifted its stake in shares of H. B. Fuller by 90.3% during the 1st quarter. Partners Capital Investment Group LLP now owns 64,901 shares of the specialty chemicals company’s stock worth $3,642,000 after purchasing an additional 30,805 shares during the period. Entropy Technologies LP acquired a new position in H. B. Fuller in the first quarter valued at $581,000. Vanguard Personalized Indexing Management LLC increased its stake in H. B. Fuller by 12.2% in the second quarter. Vanguard Personalized Indexing Management LLC now owns 9,904 shares of the specialty chemicals company’s stock valued at $596,000 after purchasing an additional 1,077 shares during the last quarter. QRG Capital Management Inc. lifted its position in H. B. Fuller by 19.1% during the second quarter. QRG Capital Management Inc. now owns 8,147 shares of the specialty chemicals company’s stock worth $490,000 after buying an additional 1,309 shares during the period. Finally, JPMorgan Chase & Co. boosted its stake in H. B. Fuller by 16.2% in the 2nd quarter. JPMorgan Chase & Co. now owns 612,048 shares of the specialty chemicals company’s stock worth $36,815,000 after buying an additional 85,469 shares during the last quarter. 95.93% of the stock is currently owned by institutional investors and hedge funds.
H. B. Fuller Company Profile
H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.
Featured Articles
- Five stocks we like better than H. B. Fuller
- 3 Fintech Stocks With Good 2021 Prospects
- Rubrik’s Massive Rebound: Why the Next Leg Higher Could Be Fast
- Insider Trades May Not Tell You What You Think
- Five Below and Dollar Tree Earnings Signal a Shopper Shift
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Ulta’s Stock May Be Set for a Glow-Up—20% Upside Ahead?
Receive News & Ratings for H. B. Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. B. Fuller and related companies with MarketBeat.com's FREE daily email newsletter.
